Company / Revenue per Share
ImmunityBio, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.13
FY2025
5-year range
$0.00 / $0.13
FY2021-FY2025
Trend
+504.3%
vs FY2024
Sector context
#131 of 154
Health Care
What the data says
Revenue per Share changed +504% YoY in FY2025, a notable deviation from the 9-year average annual change of +736%.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of +84.9%.
Improved from $0.00 to $0.13 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +503.8%
- 5-Year CAGR
- +84.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 154This company $0.13 Sector average $10.35
▼
-98.7% below sector average
Key checks
Key Insights
- ImmunityBio, Inc.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 504.3% year-over-year.
- Ranks #131 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | +504.3% |
| FY2024 | $0.02 | +1389.7% |
| FY2023 | $0.00 | +144.6% |
| FY2022 | $0.00 | -89.5% |
| FY2021 | $0.01 | -6.2% |
| FY2020 | $0.01 | -77.9% |
| FY2019 | $0.03 | +4900.4% |
| FY2018 | $0.00 | -80.7% |
| FY2017 | $0.00 | -63.5% |
| FY2016 | $0.01 | -97.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026